Immunovant IMVT
NASDAQ IMVT
$33.46 -0.03 (-0.09%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunovant (IMVT) Current Taxes (2019)

Updated

Immunovant (IMVT) posted Current Taxes of $106,000 for fiscal Q3 2020 (quarter ended Dec 31, 2019), up 236.4% from the prior quarter.

Analysis

Immunovant (IMVT) Current Taxes (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 2.31 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -1.47 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 653.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Immunovant 6.91 Bn 6.91 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 106,000.00
Sep 30, 2019 31,510.00
Jun 30, 2019 66,467.00
API Access

Immunovant Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=IMVT&period=max&api_key=YOUR_API_KEY